SEP Analytical (Shanghai) Co., Ltd. (SHE:301228)
China · Delayed Price · Currency is CNY 60.98
+4.83 (8.60%)
At close: May 7, 2026
SEP Analytical (Shanghai) Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 369.34 | 398.36 | 442.11 | 373.83 | 351.47 | 424.79 |
Other Revenue | - | - | - | - | - | 0.08 |
| 369.34 | 398.36 | 442.11 | 373.83 | 351.47 | 424.87 | |
Revenue Growth (YoY) | -19.74% | -9.89% | 18.26% | 6.36% | -17.27% | 18.05% |
Cost of Revenue | 303.01 | 317.42 | 321.87 | 300.36 | 234.91 | 254.89 |
Gross Profit | 66.33 | 80.94 | 120.24 | 73.47 | 116.56 | 169.97 |
Selling, General & Admin | 90.13 | 94.1 | 104.67 | 100.88 | 79.41 | 66.98 |
Research & Development | 23.92 | 27.08 | 31.6 | 37.24 | 41.93 | 31.51 |
Other Operating Expenses | -5.3 | -4.19 | 0.69 | -1.08 | 0.38 | 0.23 |
Operating Expenses | 108.75 | 116.99 | 182.19 | 183.21 | 159.67 | 112.26 |
Operating Income | -42.42 | -36.05 | -61.95 | -109.73 | -43.11 | 57.71 |
Interest Expense | - | - | -3.01 | -2.83 | -1.32 | -2.01 |
Interest & Investment Income | - | - | 1.75 | 7.24 | 11.71 | 0.51 |
Other Non Operating Income (Expenses) | 3.73 | -7.78 | -1.11 | -0.62 | -2.64 | -2.32 |
EBT Excluding Unusual Items | -38.69 | -43.83 | -64.32 | -105.94 | -35.36 | 53.89 |
Impairment of Goodwill | - | - | - | - | -0.05 | - |
Gain (Loss) on Sale of Investments | -6.56 | -7.06 | -1.87 | 0.34 | 0.96 | - |
Gain (Loss) on Sale of Assets | 1.62 | 1.72 | -0.45 | -1.41 | -0.51 | -0.2 |
Asset Writedown | -2.65 | -2.06 | - | -1.36 | - | - |
Other Unusual Items | - | - | 2.45 | 3.69 | 10.24 | 2.25 |
Pretax Income | -46.28 | -51.23 | -64.19 | -104.68 | -24.72 | 55.94 |
Income Tax Expense | 12.85 | 10.53 | -8.67 | -16.72 | -9 | 5.01 |
Earnings From Continuing Operations | -59.13 | -61.75 | -55.52 | -87.96 | -15.72 | 50.93 |
Minority Interest in Earnings | -5.14 | -6.25 | -10.27 | -5.58 | -2.24 | -0.5 |
Net Income | -64.26 | -68 | -65.79 | -93.54 | -17.96 | 50.43 |
Net Income to Common | -64.26 | -68 | -65.79 | -93.54 | -17.96 | 50.43 |
Net Income Growth | - | - | - | - | - | 5.47% |
Shares Outstanding (Basic) | 117 | 117 | 117 | 120 | 120 | 90 |
Shares Outstanding (Diluted) | 117 | 117 | 117 | 120 | 120 | 90 |
Shares Change (YoY) | -0.60% | -0.20% | -2.03% | 0.16% | 32.95% | -0.18% |
EPS (Basic) | -0.55 | -0.58 | -0.56 | -0.78 | -0.15 | 0.56 |
EPS (Diluted) | -0.55 | -0.58 | -0.56 | -0.78 | -0.15 | 0.56 |
EPS Growth | - | - | - | - | - | 5.66% |
Free Cash Flow | -72.46 | -18.85 | 8.24 | -54.39 | -44.82 | 57.83 |
Free Cash Flow Per Share | -0.62 | -0.16 | 0.07 | -0.45 | -0.37 | 0.64 |
Dividend Per Share | - | - | - | - | - | 0.200 |
Gross Margin | 17.96% | 20.32% | 27.20% | 19.65% | 33.16% | 40.01% |
Operating Margin | -11.49% | -9.05% | -14.01% | -29.35% | -12.27% | 13.58% |
Profit Margin | -17.40% | -17.07% | -14.88% | -25.02% | -5.11% | 11.87% |
Free Cash Flow Margin | -19.62% | -4.73% | 1.86% | -14.55% | -12.75% | 13.61% |
EBITDA | -18.7 | -10.19 | -27.58 | -66.37 | -3.17 | 96.22 |
EBITDA Margin | -5.06% | -2.56% | -6.24% | -17.75% | -0.90% | 22.65% |
D&A For EBITDA | 23.73 | 25.86 | 34.37 | 43.36 | 39.94 | 38.51 |
EBIT | -42.42 | -36.05 | -61.95 | -109.73 | -43.11 | 57.71 |
EBIT Margin | -11.49% | -9.05% | -14.01% | -29.35% | -12.27% | 13.58% |
Effective Tax Rate | - | - | - | - | - | 8.95% |
Revenue as Reported | - | - | 442.11 | 373.83 | 351.47 | 424.87 |
Advertising Expenses | - | - | 0.14 | 0.59 | 0.28 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.